Search research articles
Contact Us
Filters
Showing results (161-170 of 321) with videos related to
Page
of 33
Sort By:
Drug Safety
|
April 7, 2022
Consensus Obtained for the Nephrotoxic Potential of 167 Drugs in Adult Critically Ill Patients Using a Modified Delphi Method
Matthew P Gray, Erin F Barreto, Diana J Schreier, et al.
Mayo Clinic Proceedings
|
August 6, 2020
Patterns of Cystatin C Uptake and Use Across and Within Hospitals
Hilary R Teaford, Andrew D Rule, Kristin C Mara, et al.
Urology
|
December 3, 2014
Quantification of asymptomatic kidney stone burden by computed tomography for predicting future symptomatic stone events
Michael G Selby, Terri J Vrtiska, Amy E Krambeck, et al.
Mayo Clinic Proceedings
|
December 12, 2018
Predictors of Symptomatic Kidney Stone Recurrence After the First and Subsequent Episodes
Lisa E Vaughan, Felicity T Enders, John C Lieske, et al.
Critical Care Medicine
|
February 27, 2025
Cystatin C-Guided Dosing Nomogram Improves Target Attainment for Cefepime in the Critically Ill
Erin F Barreto, Marc H Scheetz, Jack Chang, et al.
The New England Journal of Medicine
|
June 15, 2017
Single-Nephron Glomerular Filtration Rate in Healthy Adults
Aleksandar Denic, Jerry Mathew, Lilach O Lerman, et al.
American Journal of Hypertension
|
May 31, 2006
A comparison of serum creatinine-based methods for identifying chronic kidney disease in hypertensive individuals and their siblings
Andrew D Rule, Steven J Jacobsen, Gary L Schwartz, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
January 30, 2017
Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project
Erin Frazee, Andrew D Rule, John C Lieske, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
June 30, 2012
Urolithiasis and the risk of ESRD
Ziad M El-Zoghby, John C Lieske, Robert N Foley, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes
|
May 17, 2021
Renal Outcomes in Patients with Systolic Heart Failure Treated With Sacubitril-Valsartan or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker
Nicholas Y Tan, Yihong Deng, Xiaoxi Yao, et al.
Page
of 33
Search research articles
Search
Showing results (161-170 of 321) with videos related to
Sort By:
Page
of 33
Drug Safety
|
April 7, 2022
Consensus Obtained for the Nephrotoxic Potential of 167 Drugs in Adult Critically Ill Patients Using a Modified Delphi Method
Matthew P Gray, Erin F Barreto, Diana J Schreier, et al.
Mayo Clinic Proceedings
|
August 6, 2020
Patterns of Cystatin C Uptake and Use Across and Within Hospitals
Hilary R Teaford, Andrew D Rule, Kristin C Mara, et al.
Urology
|
December 3, 2014
Quantification of asymptomatic kidney stone burden by computed tomography for predicting future symptomatic stone events
Michael G Selby, Terri J Vrtiska, Amy E Krambeck, et al.
Mayo Clinic Proceedings
|
December 12, 2018
Predictors of Symptomatic Kidney Stone Recurrence After the First and Subsequent Episodes
Lisa E Vaughan, Felicity T Enders, John C Lieske, et al.
Critical Care Medicine
|
February 27, 2025
Cystatin C-Guided Dosing Nomogram Improves Target Attainment for Cefepime in the Critically Ill
Erin F Barreto, Marc H Scheetz, Jack Chang, et al.
The New England Journal of Medicine
|
June 15, 2017
Single-Nephron Glomerular Filtration Rate in Healthy Adults
Aleksandar Denic, Jerry Mathew, Lilach O Lerman, et al.
American Journal of Hypertension
|
May 31, 2006
A comparison of serum creatinine-based methods for identifying chronic kidney disease in hypertensive individuals and their siblings
Andrew D Rule, Steven J Jacobsen, Gary L Schwartz, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
January 30, 2017
Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project
Erin Frazee, Andrew D Rule, John C Lieske, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
June 30, 2012
Urolithiasis and the risk of ESRD
Ziad M El-Zoghby, John C Lieske, Robert N Foley, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes
|
May 17, 2021
Renal Outcomes in Patients with Systolic Heart Failure Treated With Sacubitril-Valsartan or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker
Nicholas Y Tan, Yihong Deng, Xiaoxi Yao, et al.
Page
of 33